Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2692)
All Articles published online
|
Dec 15, 2004 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Liu CJ, Huang WL, Chen PJ, Lai MY, Kao JH, Chen DS. End-of-treatment virologic response does not predict relapse after lamivudine treatment for chronic hepatitis B. World J Gastroenterol 2004; 10(24): 3574-3578 [PMID: 15534909 DOI: 10.3748/wjg.v10.i24.3574] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i24/3574.htm |
| Number | Citing Articles |
| 1 |
Zebao He, Jiefei Wang, Kezhou Liu, Haibin Huang, Yao Du, Zongmei Lin, Miaoguo Cai, Xinghua Feng. Randomized trial of lamivudine, adefovir, and the combination in HBeAg-positive chronic hepatitis B. Clinics and Research in Hepatology and Gastroenterology 2012; 36(6): 592 doi: 10.1016/j.clinre.2012.05.012
|
| 2 |
Guideline on prevention and treatment of chronic hepatitis B in China (2005). Chinese Medical Journal 2007; 120(24): 2159 doi: 10.1097/00029330-200712020-00002
|
| 3 |
Shao-Ming Chiu, Yuan-Hung Kuo, Jing-Houng Wang, Chao-Hung Hung, Tsung-Hui Hu, Sheng-Nan Lu, Chien-Hung Chen. Associations of HBV Genotype B vs C Infection With Relapse After Cessation of Entecavir or Tenofovir Therapy. Clinical Gastroenterology and Hepatology 2020; 18(13): 2989 doi: 10.1016/j.cgh.2020.04.048
|
| 4 |
Chun-Jen Liu, Jia-Horng Kao. Genetic Variability of Hepatitis B virus and Response to Antiviral Therapy. Antiviral Therapy 2008; 13(5): 613 doi: 10.1177/135965350801300501
|
| 5 |
Yajun Song, Erhei Dai, Jin Wang, Hengjun Liu, Junhui Zhai, Cuiying Chen, Zongmin Du, Zhaobiao Guo, Ruifu Yang. Genotyping of hepatitis B virus (HBV) by oligonucleotides microarray. Molecular and Cellular Probes 2006; 20(2): 121 doi: 10.1016/j.mcp.2005.11.004
|
| 6 |
Tai–Chung Tseng, Chun–Jen Liu, Hung–Chih Yang, Tung–Hung Su, Chia–Chi Wang, Chi–Ling Chen, Stephanie Fang–Tzu Kuo, Chen–Hua Liu, Pei–Jer Chen, Ding–Shinn Chen, Jia–Horng Kao. High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV Load. Gastroenterology 2012; 142(5): 1140 doi: 10.1053/j.gastro.2012.02.007
|
| 7 |
Young-Joo Jin, Kang Mo Kim, Dong-jun Yoo, Ju Hyun Shim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee, Dong Jin Suh. Clinical course of chronic hepatitis B patients who were off-treated after lamivudine treatment: analysis of 138 consecutive patients. Virology Journal 2012; 9(1) doi: 10.1186/1743-422X-9-239
|
| 8 |
Chun‐Jen Liu, Jia‐Horng Kao, Ding‐Shinn Chen. Therapeutic implications of hepatitis B virus genotypes. Liver International 2005; 25(6): 1097 doi: 10.1111/j.1478-3231.2005.01177.x
|
| 9 |
Fan Mu, Liang-Shuo Hu, Kun Xu, Zhen Zhao, Bai-Cai Yang, Yi-Meng Wang, Kun Guo, Jian-Hua Shi, Yi Lv, Bo Wang. Perioperative remedial antiviral therapy in hepatitis B virus-related hepatocellular carcinoma resection: How to achieve a better outcome. World Journal of Gastrointestinal Oncology 2024; 16(5): 1833-1848 doi: 10.4251/wjgo.v16.i5.1833
|
| 10 |
James Fung, Ching-Lung Lai, Yasuhito Tanaka, Masashi Mizokami, John Yuen, Danny Ka-Ho Wong, Man-Fung Yuen. The Duration of Lamivudine Therapy for Chronic Hepatitis B: Cessation vs. Continuation of Treatment After HBeAg Seroconversion. The American Journal of Gastroenterology 2009; 104(8): 1940 doi: 10.1038/ajg.2009.200
|
| 11 |
Seong Hee Kang, Keunhee Kang, Yeon Jong Eun, Young Sun Lee, Tae Suk Kim, Yang Jae Yoo, Sang Jun Suh, Eileen L. Yoon, Young Kul Jung, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, Kwan Soo Byun. Antiviral response is not sustained after cessation of lamivudine treatment in chronic hepatitis B patients: A 10-year follow-up study. Journal of Medical Virology 2017; 89(5): 849 doi: 10.1002/jmv.24715
|